December 4, 2024 | Béla Merkely and C. Michael Gibson discuss the results of a CRT-D upgrade versus ICD alone for HFrEF patients with right ventricular pacing. Receive the the latest news, research, ...

Venous thromboembolism is a risk with several contemporary HRT formulations, consistent with earlier data. Several ...

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

An echo analysis highlights changes in the right ventricle that contribute to patient’s improved QoL with tricuspid TEER.

In the CONDUCT-TAVI study, the use of a self-expanding valve was not associated with an increased risk of pacemaker.

Lack of transparency in early studies and manufacturer summaries are among the issues uncovered during litigation.

News from the American Heart Association 2024 Scientific Sessions took seven of the 10 top slots this month.

Though X (formerly Twitter) was once a place many cardiologists found community and opportunity, many are jumping ship.

Janar Sathananthan, Ole De Backer, and Michael Reardon dive into the newest findings on TAVR from the late-breaking ACURATE ...

An increased risk of cardiovascular disease may be present as early as 30 years before a type 2 diabetes diagnosis is made, ...